US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
Cancer Novartis' Afinitor gets new EU cancer use Novartis’ Afinitor has been approved in a new cancer indication in Europe – but faces potential competition from newer drugs.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
